Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
Moodys
US Army
Dow
Colorcon
Chubb
McKesson
Julphar

Generated: July 15, 2018

DrugPatentWatch Database Preview

Prasugrel hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for prasugrel hydrochloride and what is the scope of prasugrel hydrochloride patent protection?

Prasugrel hydrochloride
is the generic ingredient in two branded drugs marketed by Eli Lilly And Co, Accord Hlthcare, Amneal Pharms, Aurobindo Pharma Ltd, Mylan Pharms Inc, Panacea Biotec Ltd, and Uspharma Windlas, and is included in seven NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Prasugrel hydrochloride has thirty-two patent family members in twenty-six countries.

There are nineteen drug master file entries for prasugrel hydrochloride. Nine suppliers are listed for this compound.
Pharmacology for prasugrel hydrochloride
Medical Subject Heading (MeSH) Categories for prasugrel hydrochloride
Synonyms for prasugrel hydrochloride
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxo-ethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate hydrochloride
[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride
2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone Hydrochloride
2-Acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride
389574-19-0
5-((1RS)-2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridin-2-yl acetate hydrochloride
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride
574C190
AB0009955
AC-24004
ACM389574190
AK124410
AKOS022185568
AM20090719
AN-6869
CAS-389574-19-0
CHEMBL1201773
CP0133
CS-1785
CTK8E7134
D05597
DSSTox_CID_28993
DSSTox_GSID_49067
DSSTox_RID_83258
DTXSID1049067
EBD36213
Effient (TN)
Ethanone, 2-(2-(acetyloxy)-6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)-1-cyclopropyl-2-(2-fluorophenyl)-, hydrochloride
Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-, hydrochloride (1:1)
FT-0656362
HY-15284A
JALHGCPDPSNJNY-UHFFFAOYSA-N
LY 640315
MFCD11867705
MolPort-006-170-137
NCGC00188690-01
NCGC00188690-02
Prasugrel (hydrochloride)
Prasugrel HCl
Prasugrel hydrochloride (JAN/USAN)
Prasugrel Hydrochloride [USAN]
Prasugrel Hydrochloride(Discontinued)
Prasugren hydrochloride
PubChem23807
RT-015128
s4637
SC-20618
SCHEMBL246128
Tox21_113621
Tox21_113621_1

US Patents and Regulatory Information for prasugrel hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc PRASUGREL prasugrel hydrochloride TABLET;ORAL 205927-001 Jul 12, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms PRASUGREL prasugrel hydrochloride TABLET;ORAL 205913-002 Jun 19, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Uspharma Windlas PRASUGREL prasugrel hydrochloride TABLET;ORAL 205790-002 Oct 16, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Eli Lilly And Co EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-001 Jul 10, 2009 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for prasugrel hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Eli Lilly And Co EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-001 Jul 10, 2009 ➤ Sign Up ➤ Sign Up
Eli Lilly And Co EFFIENT prasugrel hydrochloride TABLET;ORAL 022307-002 Jul 10, 2009 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Supplementary Protection Certificates for prasugrel hydrochloride

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB09/032 United Kingdom ➤ Sign Up PRODUCT NAME: PRASUGREL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK EU/1/08/503/001 20090225; UK EU/1/08/503/002 20090225; UK EU/1/08/503/003 20090225; UK EU/1/08/503/004 20090225
00397 Netherlands ➤ Sign Up PRODUCT NAME: PRASUGREL, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225
C0031 France ➤ Sign Up PRODUCT NAME: PRASUGREL; NAT. REGISTRATION NO/DATE: EU/1/08/503/001-014 20090225; FIRST REGISTRATION: EU/1/08/503/001/-014 20090225
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Citi
Mallinckrodt
AstraZeneca
McKesson
Chinese Patent Office
Healthtrust
Federal Trade Commission
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.